Physician decision making in selection of second-line treatments in immune thrombocytopenia in children-Reference-Cited by-同舟云学术

Physician decision making in selection of second-line treatments in immune thrombocytopenia in children

Published:2018-05-06 Issue:7 Volume:93 Page:882-888
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Grace Rachael F.¹^ORCID,Despotovic Jenny M.²,Bennett Carolyn M.³^ORCID,Bussel James B.⁴^ORCID,Neier Michelle⁵,Neunert Cindy⁶,Crary Shelley E.⁷^ORCID,Pastore Yves D.⁸,Klaassen Robert J.⁹,Rothman Jennifer A.¹⁰,Hege Kerry¹¹,Breakey Vicky R.¹²,Rose Melissa J.¹³,Shimano Kristin A.¹⁴,Buchanan George R.¹⁵,Geddis Amy¹⁶,Haley Kristina M.¹⁷,Lorenzana Adonis¹⁸,Thompson Alexis¹⁹,Jeng Michael²⁰,Neufeld Ellis J.²¹,Brown Travis¹^ORCID,Forbes Peter W.²²,Lambert Michele P.²³^ORCID

Affiliation:

1. Dana-Farber/Boston Children's Cancer and Blood Disorder Center; Boston Massachusetts

2. Texas Children's Hematology Center, Baylor College of Medicine; Houston Texas

3. Emory University School of Medicine; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center; Atlanta Georgia

4. Weill Cornell Medicine; New York New York

5. Goryeb Children's Hospital; Morristown New Jersey

6. Columbia University Medical School; New York New York

7. University of Arkansas for Medical Sciences; Little Rock Arkansas

8. CHU Sainte-Justine; Montreal Québec Canada

9. Children's Hospital of Eastern Ontario; Ottawa Ontario Canada

10. Duke University Medical Center; Durham North Carolina

11. Riley Hospital at IU Health, Indiana University School of Medicine; Indianapolis Indiana

12. McMaster University; Hamilton Ontario Canada

13. Nationwide Children's Hospital, The Ohio State University College of Medicine; Columbus Ohio

14. UCSF Benioff Children's Hospital; San Francisco California

15. University of Texas Southwestern Medical Center; Dallas Texas

16. University of Washington, Seattle Children's Hospital; Seattle Washington

17. Oregon Health & Science University; Portland Oregon

18. St. John Hospital & Medical Center; Detroit Michigan

19. Ann and Robert H. Lurie Childrens Hospital of Chicago, Northwestern University, Feinberg School of Medicine; Chicago Illinois

20. Stanford School of Medicine; Palo Alto California

21. St. Jude Children's Research Hospital; Memphis Tennessee

22. Boston Children's Hospital, Clinical Research Center; Boston Massachusetts

23. Division of Hematology; The Children's Hospital of Philadelphia; Philadelphia Pennsylvania

Funder

National Heart, Lung, and Blood Institute

Publisher

Wiley

Subject

Hematology

Reference26 articles.

1. Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review;Neunert;J Thromb Haemost.,2015

2. Severe hemorrhage in children with newly diagnosed immune thrombocytopenic purpura;Neunert;Blood.,2008

3. A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group;Kuhne;J Pediatr.,2003

4. Childhood ITP: 12 months follow-up data from the prospective registry I of the Intercontinental Childhood ITP Study Group (ICIS);Imbach;Pediatr Blood Cancer.,2006

5. The nontreatment of childhood ITP (or “the art of medicine consists of amusing the patient until nature cures the disease”);Bolton-Maggs;Semin Thromb Hemost.,2001

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: A systematic review and meta-analysis;2023-10-13

2. Prognosis and risk factors of chronicity in childhood idiopathic thrombocytopenic purpura: a single-center experience;Interdisciplinary Medical Journal;2023-04-30

3. Thrombopoietin receptor agonists and rituximab for treatment of pediatric immune thrombocytopenia: A systematic review and meta‐analysis of prospective clinical trials;Pediatric Blood & Cancer;2021-12-28

4. Psychometric Evaluation of ITP Life Quality Index (ILQI) in a Global Survey of Patients with Immune Thrombocytopenia;Advances in Therapy;2021-10-27

5. An Update on Pediatric Immune Thrombocytopenia (ITP): Differentiating Primary ITP, IPD, and PID;Blood;2021-09-03